Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Theseus Pharmaceuticals (THRX)
NASDAQ:THRX
RESEARCH TOOLSreports
Holding THRX?
Track your performance easily
Theseus Pharmaceuticals (THRX) Ownership Overview
11.99% Insiders
7.24% Mutual Funds
73.10% Other Institutional Investors
― ETFs
7.68% Public Companies and
Individual Investors
The ownership structure of Theseus Pharmaceuticals (THRX) stock is a mix of institutional, retail, and individual investors. , 11.99% is owned by Insiders, and 7.68% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 07, 2023 | William Shakespeare President Of Research And Development | xxxxxxxxxxxxx | $80347 |
| Jul 19, 2023 | Orbimed Advisors Llc Director, >10% Owner | xxxxxxxxxxxxx | $1463793 |
| Jul 19, 2023 | Carl Gordon Director, >10% Owner | xxxxxxxxxxxxx | $1463793 |
| Jul 19, 2023 | Foresite Capital Management V, Llc >10% Owner | xxxxxxxxxxxxx | $2079000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | xxxxxxxxxxxxx | $2498283 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,865,671 | Institution | 4.22% | 7,574,624 | |
| 1,400,352 | Institution | 3.17% | 5,685,429 | |
| 898,445 | Institution | 2.03% | 3,647,687 | |
| 841,570 | Institution | 1.90% | 3,416,774 | |
| 824,247 | Institution | 1.86% | 3,346,443 | |
| 711,479 | Institution | 1.61% | 2,888,605 | |
| 673,348 | Institution | 1.52% | 2,733,793 | |
| 616,860 | Institution | 1.39% | 2,504,452 | |
| 232,693 | Institution | 0.53% | 944,734 | |
| 205,505 | Institution | 0.46% | 834,350 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 898,445 | Institution | 2.03% | 3,647,687 | |
| 841,570 | Institution | 1.90% | 3,416,774 | |
| 673,348 | Institution | 1.52% | 2,733,793 | |
| 205,505 | Institution | 0.46% | 834,350 | |
| 181,186 | Institution | 0.41% | 735,615 | |
| 77,868 | Institution | 0.18% | 316,144 | |
| 70,949 | Institution | 0.16% | 288,053 | |
| 56,203 | Institution | 0.13% | 228,184 | |
| 50,000 | Institution | 0.11% | 203,000 | |
| 39,897 | Institution | 0.09% | 161,982 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 499,309 | Institution | 1.13% | 2,027,195 | |
| 241,475 | Institution | 0.55% | 980,389 | |
| 66,812 | Institution | 0.15% | 271,257 | |
| 15,143 | Institution | 0.03% | 61,481 | |
| 17,590 | Institution | 0.04% | 40,985 | |
| 1,508 | Institution | <0.01% | 6,122 |
FAQ
Who Owns Theseus Pharmaceuticals (THRX)?
According to the latest TipRanks data, approximately 73.10% of the company's stock is held by institutional investors, 11.99% is held by insiders, and 7.68% is held by retail investors.
What percentage of Theseus Pharmaceuticals (THRX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 73.10% of Theseus Pharmaceuticals (THRX) stock is held by institutional investors.
What percentage of Theseus Pharmaceuticals (THRX) stock is held by retail investors?
According to the latest TipRanks data, approximately 7.68% of Theseus Pharmaceuticals (THRX) stock is held by retail investors.
Who owns the most shares of Theseus Pharmaceuticals (THRX)?
Peter Harwin owns the most shares of Theseus Pharmaceuticals (THRX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.